Technical Analysis for MRNA - Moderna, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical MRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bearish? | Reversal | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | -0.05% | |
| Multiple of Ten Bearish | Other | -0.05% | |
| Wide Bands | Range Expansion | -0.05% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Down 2 % | 1 day ago | |
| Down 1% | 1 day ago | |
| Up 2% | 1 day ago | |
| Rose Above Previous Day's High | 1 day ago | |
| Up 1% | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/24/2021
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Coronavirus Vaccine Cancer Vaccine RNA Cancer Vaccines Messenger RNA
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Coronavirus Vaccine Cancer Vaccine RNA Cancer Vaccines Messenger RNA
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 178.5 |
| 52 Week Low | 17.91 |
| Average Volume | 26,604,214 |
| 200-Day Moving Average | 77.71 |
| 50-Day Moving Average | 119.03 |
| 20-Day Moving Average | 121.68 |
| 10-Day Moving Average | 119.03 |
| Average True Range | 9.83 |
| ADX | 21.49 |
| +DI | 25.68 |
| -DI | 18.71 |
| Chandelier Exit (Long, 3 ATRs ) | 127.79 |
| Chandelier Exit (Short, 3 ATRs ) | 132.15 |
| Upper Bollinger Band | 143.37 |
| Lower Bollinger Band | 100.00 |
| Percent B (%b) | 0.68 |
| BandWidth | 35.64 |
| MACD Line | -0.12 |
| MACD Signal Line | -1.00 |
| MACD Histogram | 0.8735 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 139.66 | ||||
| Resistance 3 (R3) | 139.76 | 136.53 | 137.99 | ||
| Resistance 2 (R2) | 136.53 | 133.98 | 136.48 | 137.44 | |
| Resistance 1 (R1) | 133.09 | 132.40 | 134.81 | 132.99 | 136.88 |
| Pivot Point | 129.85 | 129.85 | 130.71 | 129.80 | 129.85 |
| Support 1 (S1) | 126.41 | 127.30 | 128.13 | 126.31 | 122.42 |
| Support 2 (S2) | 123.18 | 125.73 | 123.13 | 121.86 | |
| Support 3 (S3) | 119.74 | 123.18 | 121.31 | ||
| Support 4 (S4) | 119.64 |
